Diversified Healthcare Trust price target raised to $3 from $2 at RBC Capital

RBC Capital raised the firm’s price target on Diversified Healthcare Trust to $3 from $2 and keeps an Underperform rating on the shares. The company is working on a few positive debt refinancings that should improve the liquidity position and reduce debt costs, but the firm remains concerned that its adjusted FFO remains negative and will likely stay negative in 2025 and possibly in 2026, the analyst tells investors in a research note.